József Szeberényi - Concepedia

Author

József Szeberényi

Also Known As

J Szeberenyi, J Szeberényi, J. Szeberenyi, J. Szeberényi, J.B. Szeberényi, JOZSEF SZEBERENYI, Jozsef SZEBERENYI, Jozsef Szeberenyi, Jozsef Szeberényi, Jozsèf Szeberènyi

182

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Pecs Dana-Farber Cancer Institute Harvard University Cancer Research Institute Virginia Cancer Institute

About

József Szeberényi is an author at University of Pecs specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	1.5K
2	Natural Sciences	5	5	148
3	Biochemistry	4	4	126
4	Social Sciences	2	2	453
5	Biology	1	1	24

József Szeberényi

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. József Szeberényi, Hong Cai, Geoffrey M. Cooper Molecular and Cellular Biology Neuronal DifferentiationCell ProliferationCell GrowthCellular NeurobiologyCell Specialization	1990	325
Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Hong Cai, József Szeberényi, Geoffrey M. Cooper Molecular and Cellular Biology Nih 3T3Signal TransductionCell RegulationSignaling PathwayOncogenic Agent	1990	231
MTH-68/H Oncolytic Viral Treatment in Human High-Grade Gliomas László K. Csatáry, Georg Gosztonyi, József Szeberényi, Journal of Neuro-Oncology Neuro-oncologyPathologyHuman High-grade GliomasHigh-grade GliomasCancer Treatment	2004	200
Different Roles for RhoA During Neurite Initiation, Elongation, and Regeneration in PC12 Cells Ágnes Sebök, Nóra Nusser, Balázs Debreceni, Journal of Neurochemistry Cell ProliferationCytoskeletonPeripheral NerveCell GrowthCellular Physiology	1999	128
Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosol. Jakob Troppmair, Joseph T. Bruder, Harald App, PubMed	1992	113
Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H). László K. Csatáry, Ralph W. Moss, J. Beuth, PubMed VaccinationVaccine SafetyAdvanced CancerVaccine DevelopmentPhase Iii	1999	89
p53-Independent Endoplasmic Reticulum Stress-Mediated Cytotoxicity of a Newcastle Disease Virus Strain in Tumor Cell Lines Zsolt Fábián, Christine M. Csatary, József Szeberényi, Journal of Virology	2007	87
Progesterone-Induced Blocking Factor Activates STAT6 via Binding to a Novel IL-4 Receptor Noémi Kozma, Melinda Halász, Beáta Polgár, The Journal of Immunology	2006	82
Anisomycin uses multiple mechanisms to stimulate mitogen‐activated protein kinases and gene expression and to inhibit neuronal differentiation in PC12 phaeochromocytoma cells Beáta Törőcsik, József Szeberényi European Journal of Neuroscience	2000	61
The effects of preconditioning on the oxidative stress in small-bowel autotransplantation Andrea Ferencz, Zalán Szántó, Balázs Borsiczky, Surgery PhysiologyGastroenterologyDigestive TractMedicineSmall-bowel Autotransplantation	2002	58

Page 1